Cargando…

Autoantibodies against desmoglein 2 are not pathogenic in pemphigus()

BACKGROUND: Anti-desmoglein 1 and 3 autoantibodies justify acantholysis in pemphigus; however, the pathogenesis of anti-desmoglein 2 is hypothetical. OBJECTIVE: To compare the participation of desmogleins 1, 2 and 3 through the production of serum autoantibodies, and protein and gene expression in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miguel, Marcela Calixto Brandão, Julio, Tamiris Amanda, Vernal, Sebastian, de Paula, Natália Aparecida, Lieber, Andre, Roselino, Ana Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073259/ https://www.ncbi.nlm.nih.gov/pubmed/35058080 http://dx.doi.org/10.1016/j.abd.2021.06.004

Ejemplares similares

Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus
por: Jerbi, Ameni, et al.
Publicado: (2021)

Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1
por: Yoshifuku, Asuka, et al.
Publicado: (2016)

Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
por: Saleh, Marwah Adly, et al.
Publicado: (2017)

Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients
por: Narbutt, Joanna, et al.
Publicado: (2012)

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity
por: Delavarian, Zahra, et al.
Publicado: (2020)

Pemphigus Foliaceus Autoantibodies Induce Redistribution Primarily of Extradesmosomal Desmoglein 1 in the Cell Membrane
por: Hiermaier, Matthias, et al.
Publicado: (2022)

Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission
por: Russo, Irene, et al.
Publicado: (2017)

Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab
por: Bhatia, Sravya M., et al.
Publicado: (2020)

Plakophilins, desmogleins, and pemphigus: the tail wagging the dog
por: Ellebrecht, Christoph T., et al.
Publicado: (2014)

Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris
por: Amber, Kyle T., et al.
Publicado: (2018)

Desmoglein compensation hypothesis fidelity assessment in Pemphigus
por: Sielski, Lauren, et al.
Publicado: (2022)

Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris
por: Schlögl, Elisabeth, et al.
Publicado: (2018)

A New Solid-Phase Immunosorbent for Selective Binding of Desmoglein 3 Autoantibodies in Patients with Pemphigus Vulgaris
por: Abramova, T. V., et al.
Publicado: (2020)

Pemphigus vulgaris associated with nasoseptal perforation, ocular conjunctival herpes infection and milia formation()
por: Vernal, Sebastian, et al.
Publicado: (2023)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
por: Lotti, Roberta, et al.
Publicado: (2023)

Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
por: Boch, Katharina, et al.
Publicado: (2021)

Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?
por: Iraji, Fariba, et al.
Publicado: (2016)

Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous
por: Lucchese, Alberta, et al.
Publicado: (2006)

Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study()
por: Fontenelle, Ludmilla Figueiredo, et al.
Publicado: (2023)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Detection of Autoantibodies against Recombinant Desmoglein 1 and 3 Molecules in Patients with Pemphigus vulgaris: Correlation with Disease Extent at the Time of Diagnosis and during Follow-Up
por: Belloni-Fortina, Anna, et al.
Publicado: (2009)

T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen
por: Takahashi, Hayato, et al.
Publicado: (2022)

Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris
por: Lo, Agnes S., et al.
Publicado: (2016)

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Hegazy, Salama, et al.
Publicado: (2016)

Keratins Regulate p38MAPK-Dependent Desmoglein Binding Properties in Pemphigus
por: Vielmuth, Franziska, et al.
Publicado: (2018)

Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin
por: Oktarina, Dyah A. M., et al.
Publicado: (2019)

Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies
por: Mohebi, Farnam, et al.
Publicado: (2020)

Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma
por: Funahashi, Shin-Ichi, et al.
Publicado: (2018)

Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients
por: Ambiel, Marcela Vendruscolo, et al.
Publicado: (2014)

Evaluation of autoantibodies to desmoglein-2 in dogs with and without cardiac disease
por: Walker, Ashley L., et al.
Publicado: (2023)

Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
Publicado: (1993)

An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris
por: Schulze, Katja, et al.
Publicado: (2011)

Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test
por: Van, Anh Tran Thi, et al.
Publicado: (2019)

Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris
por: Alshami, Muhanad Lebnan, et al.
Publicado: (2022)

Autoantibody-Specific Signalling in Pemphigus
por: Schmitt, Thomas, et al.
Publicado: (2021)

Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies
por: Gutierrez, Ericson Leonardo, et al.
Publicado: (2018)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
por: Lakoš Jukić, Ines, et al.
Publicado: (2023)

Desmoglein-2 as a prognostic and biomarker in ovarian cancer
por: Kim, Jiho, et al.
Publicado: (2020)

Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris
por: Matsuda-Hirose, Haruna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_huq9toudiv3d44903f48vfbh42